ARO-MAPT

N/A

Report date: 2025/10/28 20:00:08
NME

Base Information

Drug NameARO-MAPT
Drug Alias NameARO-MAPT
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interference
TargetsNot applicable
Therapy Area/IndicationsTauopathiesAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew Zealand
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesArrowhead Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesArrowhead Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsTauopathiesAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A